Although more than one in two HIV-infected persons may develop central fat accumulation
soon after commencing antiretroviral therapy, the association between antiretroviral therapy …

An association of increased weight with a slower progression of human immunodeficiency
virus (HIV) disease has been reported in studies that have not included large numbers of …

Since the advent of highly active antiretroviral therapy (HAART), studies have been
conflicting regarding weight information among patients with HIV. We performed a …

Objective Metabolic changes caused by antiretroviral therapy (ART) may increase the risk of
coronary heart disease (CHD). We evaluated changes in the prevalence of cardiovascular …

Background: Weight gain is common among people with HIV once antiretroviral treatment is
commenced. We assess the effect of changes in body mass index (BMI), from different …

Objectives With the use of potent antiretroviral therapy in patients with HIV disease, changes
in lipid parameters and glucose homeostasis have been noted. However, these effects have …

Background In HIV-infected patients, combination antiretroviral therapy (cART) is associated
with clinical lipodystrophy (CL) and metabolic abnormalities (MA). This study aimed to …

Race/sex differences are observed in cardiometabolic disease (CMD) risk and prevalence in
the context of treated, chronic HIV infection, and these differences could be exacerbated by …

Identifying risk factors associated with overweight and obesity in HIV-infected patients. A
cross-sectional study analyzing data from patients attending an HIV outpatient unit …

Background Although combined antiretroviral therapy has substantially improved the
prognosis of people living with HIV (PLHIV), mortality remains higher compared to the …